Diagonal Bio AB
Developing a platform for ultra-fast, PCR-accurate diagnostics of infectious diseases.
DIABIO | ST
Overview
Corporate Details
- ISIN(s):
- SE0015961826
- LEI:
- 9845000469E56665DD98
- Country:
- Sweden
- Address:
- Medicon Village, Scheeletorget 1, 223 81 Lund
- Website:
- https://diagonalbio.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of medical and dental instruments and supplies
Description
Diagonal Bio AB is a medical technology company developing the PANVIRAL® platform for ultra-fast diagnostics. The company's patented technology combines molecular biology and electrochemistry to enable rapid and accurate identification of genetic markers from pathogens such as viruses, bacteria, and fungi. The platform is designed to deliver semi-quantitative, PCR-standard accuracy results from DNA or RNA samples in 10-15 minutes. Founded in 2020, Diagonal Bio aims to decentralize infectious disease testing by providing a solution that reduces the reliance on large, complex, and costly centralized laboratories, thereby revolutionizing global diagnostics to limit the spread of disease.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Diagonal Bio AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Diagonal Bio AB
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Diagonal Bio AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
